BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kao TW, Huang CC. Inflammatory Burden and Immunomodulative Therapeutics of Cardiovascular Diseases. Int J Mol Sci 2022;23:804. [PMID: 35054989 DOI: 10.3390/ijms23020804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li S, He J, Zhang X, Cai Y, Liu J, Nie X, Shi L. Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.966182] [Reference Citation Analysis]
2 Duan X, Li J, Cui J, Wen H, Xin X, Aisa HA. A network pharmacology strategy combined with in vitro experiments to investigate the potential anti-inflammatory mechanism of Prunus cerasifera Ehrhart. J Food Biochem 2022;:e14396. [PMID: 36169283 DOI: 10.1111/jfbc.14396] [Reference Citation Analysis]
3 Feng X, Zhang Y, Du M, Li S, Ding J, Wang J, Wang Y, Liu P. Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease. J Transl Med 2022;20:399. [PMID: 36064568 DOI: 10.1186/s12967-022-03614-1] [Reference Citation Analysis]
4 Amedei A. Editorial of Special Issue “The Interplay of Microbiome and Immune Response in Health and Diseases—2nd Edition”. IJMS 2022;23:7169. [DOI: 10.3390/ijms23137169] [Reference Citation Analysis]